ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001765253

Versant Vantage I, L.P.

CIK 0001765253 Name as filed on the most recent filing

Filed as Versant Vantage I, L.P. (29)

104 transaction lines · from 29 filings · filed 2019-10-07 to 2025-09-23 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2025-09-19 Lava Therapeutics NV
LVTX 		S, Open-market sale 2,370,533 disposed 1.40 3,322,064.95 Form 4, filing 0001193125-25-213445
2025-09-19 Lava Therapeutics NV
LVTX 		S, Open-market sale 532,870 disposed 1.40 746,764.02 Form 4, filing 0001193125-25-213445
2025-09-18 Lava Therapeutics NV
LVTX 		S, Open-market sale 366,111 disposed 1.44 527,858.84 Form 4, filing 0001193125-25-207677
2025-09-18 Lava Therapeutics NV
LVTX 		S, Open-market sale 228,791 disposed 1.44 329,870.86 Form 4, filing 0001193125-25-207677
2025-09-17 Lava Therapeutics NV
LVTX 		S, Open-market sale 362,806 disposed 1.49 540,290.70 Form 4, filing 0001193125-25-207677
2025-09-17 Lava Therapeutics NV
LVTX 		S, Open-market sale 226,726 disposed 1.49 337,640.36 Form 4, filing 0001193125-25-207677
2025-09-16 Lava Therapeutics NV
LVTX 		S, Open-market sale 307,707 disposed 1.53 471,776.37 Form 4, filing 0001193125-25-207677
2025-09-16 Lava Therapeutics NV
LVTX 		S, Open-market sale 192,293 disposed 1.53 294,823.63 Form 4, filing 0001193125-25-207677
2024-10-29 Monte Rosa Therapeutics, Inc.
GLUE 		S, Open-market sale 52,305 disposed 9.08 475,007.86 Form 4, filing 0000950170-24-119051
2024-10-29 Monte Rosa Therapeutics, Inc.
GLUE 		S, Open-market sale 15,600 disposed 9.41 146,792.88 Form 4, filing 0000950170-24-119051
2024-10-28 Monte Rosa Therapeutics, Inc.
GLUE 		S, Open-market sale 89,990 disposed 9.66 869,240.41 Form 4, filing 0000950170-24-119051
2024-09-20 Monte Rosa Therapeutics, Inc.
GLUE 		S, Open-market sale 1,132,566 disposed 6.53 7,395,202.95 Form 4, filing 0000950170-24-109112
2024-09-13 Monte Rosa Therapeutics, Inc.
GLUE 		S, Open-market sale 9,269 disposed 6.16 57,099.82 Form 4, filing 0000950170-24-106532
2024-09-12 Monte Rosa Therapeutics, Inc.
GLUE 		S, Open-market sale 16,047 disposed 6.00 96,309.28 Form 4, filing 0000950170-24-106532
2024-09-11 Monte Rosa Therapeutics, Inc.
GLUE 		S, Open-market sale 541,897 disposed 6.00 3,251,382.00 Form 4, filing 0000950170-24-106532
2024-08-28 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 221,600 disposed 6.32 1,400,556.32 Form 4, filing 0000950170-24-102354
2022-06-03 Repare Therapeutics Inc.
RPTX 		S, Open-market sale 438,795 disposed 12.25 5,375,984.70 Form 4, filing 0000899243-22-021350
2022-06-03 Repare Therapeutics Inc.
RPTX 		S, Open-market sale 250,000 disposed 12.25 3,062,925.00 Form 4, filing 0000899243-22-021350
2022-06-03 Repare Therapeutics Inc.
RPTX 		S, Open-market sale 33,395 disposed 12.25 409,145.52 Form 4, filing 0000899243-22-021350
2022-06-03 Repare Therapeutics Inc.
RPTX 		S, Open-market sale 14,611 disposed 12.25 179,009.59 Form 4, filing 0000899243-22-021350
2022-06-03 Repare Therapeutics Inc.
RPTX 		S, Open-market sale 13,199 disposed 12.25 161,710.19 Form 4, filing 0000899243-22-021350
2021-10-18 Oyster Point Pharma, Inc.
OYST 		S, Open-market sale 303,614 disposed 14.63 4,442,692.58 Form 4, filing 0000899243-21-040777
2021-10-18 Oyster Point Pharma, Inc.
OYST 		S, Open-market sale 242,943 disposed 15.09 3,666,957.35 Form 4, filing 0000899243-21-040777
2021-10-18 Oyster Point Pharma, Inc.
OYST 		S, Open-market sale 1,912 disposed 14.63 27,977.72 Form 4, filing 0000899243-21-040777
2021-10-18 Oyster Point Pharma, Inc.
OYST 		S, Open-market sale 1,531 disposed 15.09 23,108.76 Form 4, filing 0000899243-21-040777
2021-06-28 Monte Rosa Therapeutics, Inc.
GLUE 		P, Open-market purchase 157,895 acquired 19.00 3,000,005.00 Form 4, filing 0000899243-21-026766
2020-11-30 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 10,193 disposed 33.13 337,679.82 Form 4, filing 0000899243-20-032389
2020-11-30 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 200 disposed 34.16 6,832.92 Form 4, filing 0000899243-20-032389
2020-11-19 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 114,854 disposed 33.01 3,791,330.54 Form 4, filing 0000899243-20-031918
2020-11-19 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 15,163 disposed 33.01 500,530.63 Form 4, filing 0000899243-20-031918
2020-11-18 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 473 disposed 33.09 15,653.37 Form 4, filing 0000899243-20-031771
2020-11-18 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 63 disposed 33.09 2,084.91 Form 4, filing 0000899243-20-031771
2020-11-17 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 3,705 disposed 33.05 122,449.51 Form 4, filing 0000899243-20-031771
2020-11-17 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 489 disposed 33.05 16,161.35 Form 4, filing 0000899243-20-031771
2020-11-16 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 177 disposed 33.01 5,843.21 Form 4, filing 0000899243-20-031322
2020-11-16 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 23 disposed 33.01 759.29 Form 4, filing 0000899243-20-031322
2020-11-13 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 2,473 disposed 33.31 82,387.75 Form 4, filing 0000899243-20-031322
2020-11-13 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 1,502 disposed 34.53 51,865.41 Form 4, filing 0000899243-20-031322
2020-11-13 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 327 disposed 33.31 10,893.97 Form 4, filing 0000899243-20-031322
2020-11-13 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 198 disposed 34.53 6,837.12 Form 4, filing 0000899243-20-031322
2020-11-12 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 9,450 disposed 34.39 325,011.96 Form 4, filing 0000899243-20-031061
2020-11-12 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 3,976 disposed 33.48 133,106.14 Form 4, filing 0000899243-20-031061
2020-11-12 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 1,248 disposed 34.39 42,922.21 Form 4, filing 0000899243-20-031061
2020-11-12 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 524 disposed 33.48 17,542.16 Form 4, filing 0000899243-20-031061
2020-11-12 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 353 disposed 35.15 12,407.53 Form 4, filing 0000899243-20-031061
2020-11-12 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 47 disposed 35.15 1,651.99 Form 4, filing 0000899243-20-031061
2020-11-11 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 9,027 disposed 34.94 315,378.10 Form 4, filing 0000899243-20-030855
2020-11-11 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 2,119 disposed 33.86 71,748.49 Form 4, filing 0000899243-20-030855
2020-11-11 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 1,191 disposed 34.94 41,610.21 Form 4, filing 0000899243-20-030855
2020-11-11 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 280 disposed 33.86 9,480.69 Form 4, filing 0000899243-20-030855

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Versant Vantage I, L.P., insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001765253

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.